USD 0.04
(-1.64%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -13.48 Million USD | 83.82% |
2022 | 35.2 Million USD | 23.43% |
2021 | -105.11 Million USD | -25.28% |
2020 | -91.33 Million USD | -29.79% |
2019 | -68.11 Million USD | -84.66% |
2018 | -40.55 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -2.02 Million USD | 548.56% |
2024 Q1 | -2.82 Million USD | -100.97% |
2023 Q1 | -15.93 Million USD | 13.84% |
2023 FY | - USD | 83.82% |
2023 Q3 | -13.78 Million USD | 17.1% |
2023 Q2 | -16.63 Million USD | -4.35% |
2023 Q4 | 32.42 Million USD | 335.15% |
2022 Q3 | -16.97 Million USD | 34.14% |
2022 Q2 | -25.77 Million USD | -8.58% |
2022 Q1 | -23.73 Million USD | 21.54% |
2022 FY | - USD | 23.43% |
2022 Q4 | -18.49 Million USD | -8.98% |
2021 FY | - USD | -25.28% |
2021 Q3 | -27.23 Million USD | -5.95% |
2021 Q4 | -30.25 Million USD | -11.11% |
2021 Q2 | -25.7 Million USD | 6.08% |
2021 Q1 | -27.36 Million USD | -3.66% |
2020 Q3 | -25.06 Million USD | -33.78% |
2020 Q2 | -18.73 Million USD | 0.54% |
2020 Q1 | -18.83 Million USD | -19.53% |
2020 FY | - USD | -29.79% |
2020 Q4 | -26.4 Million USD | -5.33% |
2019 Q1 | -9.06 Million USD | 0.0% |
2019 FY | - USD | -84.66% |
2019 Q4 | -15.75 Million USD | 45.89% |
2019 Q3 | -29.12 Million USD | -123.96% |
2019 Q2 | -13 Million USD | -43.38% |
2018 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Cerus Corporation | -26.53 Million USD | 49.175% |
OrthoPediatrics Corp. | -8.38 Million USD | -60.924% |
PetVivo Holdings, Inc. | -10.49 Million USD | -28.515% |
Talis Biomedical Corporation | -66.04 Million USD | 79.579% |
Vivos Therapeutics, Inc. | -16.67 Million USD | 19.118% |
Inogen, Inc. | -45.67 Million USD | 70.474% |
Spectral AI, Inc. | -12.26 Million USD | -9.99% |
Nano-X Imaging Ltd. | -47.69 Million USD | 71.721% |
CVRx, Inc. | -38.73 Million USD | 65.178% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -282.285% |
Helius Medical Technologies, Inc. | -12.1 Million USD | -11.398% |
Orthofix Medical Inc. | -86.98 Million USD | 84.495% |
Venus Concept Inc. | -26.11 Million USD | 48.351% |
Accelerate Diagnostics, Inc. | -49.77 Million USD | 72.902% |
Bioventus Inc. | -23.07 Million USD | 41.539% |
BrainsWay Ltd. | -2.31 Million USD | -483.6% |
Envoy Medical, Inc. | -18.23 Million USD | 26.05% |
electroCore, Inc. | -17.76 Million USD | 24.06% |
IceCure Medical Ltd | -15.25 Million USD | 11.578% |
Lucid Diagnostics Inc. | -49.75 Million USD | 72.891% |
Monogram Orthopaedics, Inc. | -16.85 Million USD | 19.985% |
MaxCyte, Inc. | -44.12 Million USD | 69.437% |
NeuroOne Medical Technologies Corporation | -11.75 Million USD | -14.725% |
Nexalin Technology, Inc. | -5.69 Million USD | -136.945% |
PAVmed Inc | -75.74 Million USD | 82.193% |
Rapid Micro Biosystems, Inc. | -53.75 Million USD | 74.912% |
RxSight, Inc. | -41.03 Million USD | 67.135% |
Sight Sciences, Inc. | -49.41 Million USD | 72.707% |
SI-BONE, Inc. | -34.44 Million USD | 60.846% |
TELA Bio, Inc. | -40.63 Million USD | 66.808% |
TriSalus Life Sciences, Inc. | -58.29 Million USD | 76.865% |
Treace Medical Concepts, Inc. | -39 Million USD | 65.425% |
LivaNova PLC | 39.01 Million USD | 134.568% |
908 Devices Inc. | -34.02 Million USD | 60.361% |
Alphatec Holdings, Inc. | -110.59 Million USD | 87.805% |
Nemaura Medical Inc. | -7.28 Million USD | -85.082% |
NeuroPace, Inc. | -22.83 Million USD | 40.935% |
LENSAR, Inc. | -8.71 Million USD | -54.774% |
Apyx Medical Corporation | -18.11 Million USD | 25.536% |
Cutera, Inc. | -136.56 Million USD | 90.124% |
STRATA Skin Sciences, Inc. | -3.38 Million USD | -299.024% |
BioSig Technologies, Inc. | -28.15 Million USD | 52.091% |
Anika Therapeutics, Inc. | 2.51 Million USD | 636.049% |
ClearPoint Neuro, Inc. | -20.98 Million USD | 35.743% |
Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.516% |
Axonics, Inc. | 7.77 Million USD | 273.466% |
Outset Medical, Inc. | -153.78 Million USD | 91.23% |
IRIDEX Corporation | -7.44 Million USD | -81.082% |
PROCEPT BioRobotics Corporation | -98.09 Million USD | 86.251% |
IRadimed Corporation | 20.8 Million USD | 164.839% |
Tivic Health Systems, Inc. | -8.06 Million USD | -67.291% |
INVO Bioscience, Inc. | -6.88 Million USD | -96.031% |
Telesis Bio, Inc. | -40.49 Million USD | 66.693% |
Viemed Healthcare, Inc. | 36.67 Million USD | 136.772% |
Varex Imaging Corporation | 67.2 Million USD | 120.07% |
Quipt Home Medical Corp. | 44.07 Million USD | 130.603% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -24.075% |
Pulmonx Corporation | -55.09 Million USD | 75.519% |
Dynatronics Corporation | -976 Thousand USD | -1281.853% |
Modular Medical, Inc. | -17.1 Million USD | 21.142% |
ReShape Lifesciences Inc. | -14.48 Million USD | 6.89% |
Semler Scientific, Inc. | 23.58 Million USD | 157.175% |
InMode Ltd. | 196.28 Million USD | 106.871% |
Bruker Corporation | 599 Million USD | 102.252% |
Cytosorbents Corporation | -28.81 Million USD | 53.188% |
DexCom, Inc. | 916.7 Million USD | 101.471% |
Align Technology, Inc. | 799.03 Million USD | 101.688% |
Viveve Medical, Inc. | -20.61 Million USD | 34.583% |
ZimVie Inc. | 91.07 Million USD | 114.809% |
Movano Inc. | -29.12 Million USD | 53.693% |
Cytek Biosciences, Inc. | -4.4 Million USD | -205.966% |
Nexalin Technology, Inc. | -5.69 Million USD | -136.945% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -282.285% |
Tandem Diabetes Care, Inc. | -194.65 Million USD | 93.071% |
Profound Medical Corp. | -27.12 Million USD | 50.276% |
Insulet Corporation | 323.6 Million USD | 104.168% |
enVVeno Medical Corporation | -25.01 Million USD | 46.091% |
Surmodics, Inc. | 1.18 Million USD | 1235.269% |
iCAD, Inc. | -6.56 Million USD | -105.438% |
Nuwellis, Inc. | -16.35 Million USD | 17.541% |
Biotricity, Inc. | -8.82 Million USD | -52.771% |
iRhythm Technologies, Inc. | -96.86 Million USD | 86.076% |
Aethlon Medical, Inc. | -11.84 Million USD | -13.823% |
InspireMD, Inc. | -20.91 Million USD | 35.503% |
PAVmed Inc. | -75.74 Million USD | 82.193% |
BIOLASE, Inc. | -15.13 Million USD | 10.912% |
Beyond Air, Inc. | -59.03 Million USD | 77.153% |
FONAR Corporation | 28.25 Million USD | 147.739% |
AxoGen, Inc. | -13.32 Million USD | -1.193% |
Vivani Medical, Inc. | -26.6 Million USD | 49.312% |
Tactile Systems Technology, Inc. | 24.54 Million USD | 154.957% |
Inari Medical, Inc. | 7.11 Million USD | 289.611% |
UFP Technologies, Inc. | 72.74 Million USD | 118.541% |
QT Imaging Holdings, Inc. | -3.38 Million USD | -298.342% |
Heart Test Laboratories, Inc. | -6.15 Million USD | -119.087% |
Tenon Medical, Inc. | -15.52 Million USD | 13.144% |
Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 11.653% |
Co-Diagnostics, Inc. | -41.47 Million USD | 67.482% |
AdaptHealth Corp. | -171.09 Million USD | 92.117% |
Sintx Technologies, Inc. | -6.6 Million USD | -104.348% |
NanoVibronix, Inc. | -3.43 Million USD | -292.635% |
Quanterix Corporation | -38.08 Million USD | 64.59% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -24.075% |
Sensus Healthcare, Inc. | 30 Thousand USD | 45056.667% |
Pacific Biosciences of California, Inc. | -277.28 Million USD | 95.136% |
TransMedics Group, Inc. | -7.6 Million USD | -77.391% |
ReWalk Robotics Ltd. | -21.76 Million USD | 38.034% |
NeuroMetrix, Inc. | -7.09 Million USD | -90.07% |
Hyperfine, Inc. | -47.06 Million USD | 71.341% |
Establishment Labs Holdings Inc. | -58.3 Million USD | 76.869% |
Biomerica, Inc. | -5.99 Million USD | -125.046% |
Bone Biologics Corporation | 479.57 Thousand USD | 2912.299% |
AVITA Medical, Inc. | -39.56 Million USD | 65.914% |
Bluejay Diagnostics, Inc. | -9.17 Million USD | -47.03% |
Silk Road Medical, Inc | -45.08 Million USD | 70.082% |